Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.920
-0.050 (-1.00%)
Sep 9, 2025, 9:57 AM - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $58.00 million as of September 9, 2025. Its market cap has decreased by -18.44% in one year.
Market Cap
58.00M
Enterprise Value
25.78M
1-Year Change
-18.44%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $58.00M, a decrease of -93.22%. That is a compound annual growth rate of -34.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 58.58M | 100.44% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |